Literature DB >> 29668022

Follow-Up Care for High-Risk Preterm Infants.

Stephannie M B Voller.   

Abstract

Preterm infants continue to have complex medical and developmental issues after discharge from the neonatal intensive care unit. Over the past few decades there has been an increase in preterm births and a decrease in preterm mortality. Many infants are referred to follow-up clinics that specialize in neurodevelopmental assessment. Often, a community pediatrician or family practitioner provides both the medical management and observes developmental milestones of the high-risk neonate. Intense medical management, early identification of delay, and referral for developmental services may improve preterm infant outcomes. This article provides an overview of common medical and developmental problems specific to high-risk preterm infants. [Pediatr Ann. 2018;47(4):e142-e146.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Year:  2018        PMID: 29668022     DOI: 10.3928/19382359-20180325-03

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN: 0090-4481            Impact factor:   1.132


  3 in total

1.  Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.

Authors:  Rebecca MacDonell-Yilmaz; Kelly Anderson; Bradley DeNardo; Philippa Sprinz; William V Padula
Journal:  J Pediatr       Date:  2020-05-26       Impact factor: 4.406

2.  A journey through follow-up for neurodevelopmentally at-risk infants-A qualitative study on views of parents and professionals in Liverpool.

Authors:  Ayuko Komoriyama; Fauzia Paize; Esme Littlefair; Chris Dewhurst; Melissa Gladstone
Journal:  Child Care Health Dev       Date:  2019-07-30       Impact factor: 2.508

3.  Follow-up care for premature children: the repercussions of the COVID-19 pandemic.

Authors:  Rosane Meire Munhak da Silva; Letícia Pancieri; Adriana Zilly; Fabiana Aparecida Spohr; Luciana Mara Monti Fonseca; Débora Falleiros de Mello
Journal:  Rev Lat Am Enfermagem       Date:  2021-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.